What’s good is a one trick orphan pony trading at near $31 - so many fools around me thinks.
Plenty of speccies drop >95% once the hype wears off.
A new indication means new trials and new approvals. The fact that there is 20 years of safety data actually means very little. eg Aspirin still needed multiple trials to be approved to treat heart disease despite nearly 100 years of OTC use. The approval rate is only 5--10%.
What’s good is a one trick orphan pony trading at near $31 - so...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.38 |
Change
2.210(14.6%) |
Mkt cap ! $870.8M | |||
| Open | High | Low | Value | Volume |
| $15.20 | $17.71 | $15.16 | $5.878M | 346.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $17.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.39 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |